CDC updates RSV vaccine recommendations for older adults
The Centers for Disease Control and Prevention has updated respiratory syncytial virus vaccination recommendations for adults 60 and older.
www.aha.orgHere’s the latest on RSV vaccine eligibility based on recent public health guidance.
-
In 2024–2025, updated CDC guidelines expanded eligibility for many adults, especially seniors. The CDC began recommending RSV vaccination for all adults aged 75 and older, and for adults aged 60–74 who have increased risk for severe RSV disease due to underlying health conditions or living circumstances. This reflects a shift from earlier, broader 60+ eligibility to a more targeted high-risk approach among the 60–74 group. [Source: CDC updates and related coverage in 2024–2025 materials][4][7]
-
More recently, there were developments suggesting additional age groups could be considered for vaccination in certain contexts, including some guidance discussions about adults aged 50–59 with specific risk factors, as well as recommendations tied to pregnancy to protect newborns. The exact eligibility criteria for 50–59-year-olds were being evaluated and discussed by ACIP/CDC in 2024–2025, with outcomes pending final CDC director approval.[2][3]
-
Federal agencies and major vaccine manufacturers have continued to communicate about expanding indications (e.g., vaccines authorized for adults 18–59 at risk of severe RSV, and maternal vaccination during pregnancy), but final, national-level eligibility for these groups depends on final CDC/ACIP decisions and FDA approvals. If you’re seeking current eligibility for a specific state or individual, check the latest CDC RSV vaccines page and your local health department updates.[3][8][4]
Practical takeaways for you
- If you’re 75+, you’re broadly eligible for RSV vaccination under current CDC guidance. If you’re 60–74, eligibility depends on whether you have certain risk factors and living situations; a clinician can assess whether you qualify.[7][4]
- Pregnant people in their 32–36 weeks of gestation are commonly targeted for maternal vaccination during RSV season to protect newborns.[5]
Illustration: an RSV vaccination path
- Age 75+: recommended
- Age 60–74: assess risk factors (e.g., heart disease, living in a nursing home, frailty, obesity) to determine eligibility
- Pregnancy: maternal vaccination window (32–36 weeks) during RSV season
- Age 50–59: under review; may be eligible if high risk, depending on final guidelines
If you’d like, I can pull the exact current CDC page and summarize the latest concrete eligibility criteria for your location in São Paulo, Brazil, including any local vaccination programs or supplier availability. Please confirm if you want country-specific guidance.[8]